RSCM
NBRV
Rock Springs Capital Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-1,067,664
| Closed | -$569K | – | 165 |
|
2020
Q3 | $569K | Hold |
1,067,664
| – | – | 0.01% | 147 |
|
2020
Q2 | $720K | Buy |
1,067,664
+17,664
| +2% | +$11.9K | 0.02% | 141 |
|
2020
Q1 | $604K | Sell |
1,050,000
-1,050,000
| -50% | -$604K | 0.03% | 130 |
|
2019
Q4 | $2.77M | Sell |
2,100,000
-200,000
| -9% | -$264K | 0.09% | 115 |
|
2019
Q3 | $4.6M | Buy |
2,300,000
+700,000
| +44% | +$1.4M | 0.18% | 108 |
|
2019
Q2 | $3.89M | Hold |
1,600,000
| – | – | 0.14% | 115 |
|
2019
Q1 | $3.9M | Hold |
1,600,000
| – | – | 0.15% | 110 |
|
2018
Q4 | $2.34M | Sell |
1,600,000
-200,000
| -11% | -$292K | 0.11% | 120 |
|
2018
Q3 | $4.86M | Buy |
1,800,000
+1,160,000
| +181% | +$3.13M | 0.18% | 119 |
|
2018
Q2 | $2.23M | Buy |
640,000
+15,000
| +2% | +$52.2K | 0.09% | 133 |
|
2018
Q1 | $3.14M | Hold |
625,000
| – | – | 0.13% | 132 |
|
2017
Q4 | $3.74M | Hold |
625,000
| – | – | 0.17% | 117 |
|
2017
Q3 | $5.12M | Buy |
625,000
+100,000
| +19% | +$819K | 0.24% | 103 |
|
2017
Q2 | $5.5M | Hold |
525,000
| – | – | 0.28% | 91 |
|
2017
Q1 | $6.3M | Hold |
525,000
| – | – | 0.36% | 79 |
|
2016
Q4 | $3.12M | Buy |
525,000
+99,000
| +23% | +$589K | 0.21% | 96 |
|
2016
Q3 | $3M | Hold |
426,000
| – | – | 0.19% | 107 |
|
2016
Q2 | $3.2M | Buy |
426,000
+46,000
| +12% | +$345K | 0.24% | 102 |
|
2016
Q1 | $3.41M | Buy |
380,000
+145,000
| +62% | +$1.3M | 0.29% | 95 |
|
2015
Q4 | $2.24M | Sell |
235,000
-89,400
| -28% | -$854K | 0.17% | 108 |
|
2015
Q3 | $3.08M | Buy |
+324,400
| New | +$3.08M | 0.25% | 104 |
|